Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies

ClinicalTrials.gov ID: NCT00014235

Public ClinicalTrials.gov record NCT00014235. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 21, 2026, 12:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Nonmyeloablative PBSC Allografting From HLA Matched Related Donors Using Fludarabine and/or Low Dose TBI With Disease-Risk Based Immunosuppression

Study identification

NCT ID: NCT00014235
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: Fred Hutchinson Cancer Center; Other
Enrollment: 160 participants

Conditions and interventions

Conditions

Interventions

allogeneic hematopoietic stem cell transplantation Procedure
cyclosporine Drug
fludarabine phosphate Drug
laboratory biomarker analysis Other
mycophenolate mofetil Drug
peripheral blood stem cell transplantation Procedure
total-body irradiation Radiation

Procedure · Drug · Other + 1 more

Eligibility (public fields only)

Age range: Up to 74 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 30, 2000
Primary completion: Jan 31, 2005
Completion: Not listed
Last update posted: Jan 20, 2020

Started 2000

United States locations

U.S. sites: 9
U.S. states: 7
U.S. cities: 8

Facility	City	State	ZIP	Site status
University of Arizona Health Sciences Center	Tucson	Arizona	85724	—
City of Hope Medical Center	Duarte	California	91010	—
Stanford University Hospitals and Clinics	Stanford	California	94305	—
OHSU Knight Cancer Institute	Portland	Oregon	97239	—
Baylor University Medical Center	Dallas	Texas	75246	—
Huntsman Cancer Institute/University of Utah	Salt Lake City	Utah	84112	—
LDS Hospital	Salt Lake City	Utah	84143	—
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium	Seattle	Washington	98109	—
Froedtert Hospital	Milwaukee	Wisconsin	53226-3596	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00014235, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 20, 2020 · Synced May 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00014235 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →